BioStem Technologies prices USD 3 million at-the-market private placement under Nasdaq rules

• BioStem Technologies priced a USD 3 million at-the-market private placement of 735,296 common shares at USD 4.08 each.
• Deal includes Series A warrants for 735,296 shares plus Series B warrants for 735,296 shares, exercisable immediately at USD 3.83.
• Warrants could raise an additional USD 5.6 million if fully exercised for cash.
• Closing expected Sept. 30, 2026; proceeds earmarked for working capital and general corporate purposes.
• H.C. Wainwright is exclusive placement agent.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biostem Technologies Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609300800PRIMZONEFULLFEED9836770) on September 30, 2026, and is solely responsible for the information contained therein.